Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Shiying Kong"'
Autor:
Victor H. Jimenez‐Zepeda, Donna Reece, Rodrigo Rigo, Priyanka Gogna, Shiying Kong, Xun Yang Hu, Parv Chapani, Winson Y. Cheung, Darren R. Brenner, Richard Plante, Kun Shi, Asad Husain, Dipti Tankala, Devon J. Boyne
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1262-1269 (2022)
Abstract Amyloid light chain (AL) amyloidosis is a rare and chronic bone marrow disorder. Existing claims data can be used to help understand the real‐world treatment patterns and outcomes of this patient population. Various population‐based admi
Externí odkaz:
https://doaj.org/article/8a03f5fca1404604871eed4b9fc80ec6
Autor:
Daniel Breadner, Jonathan M. Loree, Winson Y. Cheung, Meghan Gipson, Suganija Lakkunarajah, Karen E. Mulder, Jennifer L. Spartlin, Shiying Kong, Philip Q. Ding, Sharlene Gill, Stephen A. Welch
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon cancer (CC) reduces cancer recurrence, but also causes significant to
Externí odkaz:
https://doaj.org/article/1d997dd7e2c34753b98355ea02900e26
Autor:
Robert Carroll, Margherita Bortolini, Alan Calleja, Robin Munro, Shiying Kong, Melinda J. Daumont, John R. Penrod, Khalid Lakhdari, Laure Lacoin, Winson Y. Cheung
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background As part of the multi-country I-O Optimise research initiative, this population-based study evaluated real-world treatment patterns and overall survival (OS) in patients treated for advanced non-small cell lung cancer (NSCLC) befor
Externí odkaz:
https://doaj.org/article/0ba5868d52ff465b9d005bba6c07af14
Autor:
Hyunmin Jung, Mingshan Lu, May Lynn Quan, Winson Y. Cheung, Shiying Kong, Sasha Lupichuk, Yuanchao Feng, Yuan Xu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up stud
Externí odkaz:
https://doaj.org/article/4ef0610162244ec0b57d29830cd012ea
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1298-1308 (2022)
Purpose: This study aimed to determine the real-world prognostic significance of lymph node ratio (LNR) and log odds of positive lymph nodes (LOPLN) in patients with non-metastatic small bowel adenocarcinoma. Methods: Patients diagnosed with early-st
Externí odkaz:
https://doaj.org/article/f244a20bede549f090e68b35bf95bb7f
Autor:
Che Hsuan David Wu, May Lynn Quan, Shiying Kong, Yuan Xu, Jeffrey Q. Cao, Sasha Lupichuk, Lisa Barbera
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4420-4431 (2021)
Breast cancer patients receiving adjuvant chemotherapy are at increased risk of acute care use. The incidence of emergency department (ED) visits and hospitalizations (H) have been characterized in other provinces but never in Alberta. We conducted a
Externí odkaz:
https://doaj.org/article/5ee15d0f8f85416aa03a78115ff733ee
Autor:
Abdulla Al-Rashdan, Yuan Xu, May Lynn Quan, Jeffrey Q. Cao, Winson Cheung, Antoine Bouchard-Fortier, Shiying Kong, Lisa Barbera
Publikováno v:
Breast, Vol 59, Iss , Pp 203-210 (2021)
Background: To understand the association between various treatments and survival for older women with higher-risk breast cancer when controlling for patient and tumor factors. Materials and methods: We conducted a retrospective, population-based stu
Externí odkaz:
https://doaj.org/article/275ee83428734de69bc432e16dbd0fe3
Autor:
Rodrigo Rigo, Jordan Doherty, Kim Koczka, Shiying Kong, Philip Q. Ding, Tina Cheng, Winson Y. Cheung, Jose G. Monzon
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3978-3986 (2021)
Immune checkpoint and MAP kinase pathway inhibitors can significantly improve long-term survival for patients with melanoma. There is limited real-world data of these regimens’ effectiveness. We retrospectively analyzed 402 patients with unresectab
Externí odkaz:
https://doaj.org/article/1ed2b878f5f14461985de358d55e844e
Autor:
Heidi A. I. Grosjean, Samantha Dolter, Daniel E. Meyers, Philip Q. Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y. C. Heng, D. Gwyn Bebb, Don G. Morris, Winson Y. Cheung, Aliyah Pabani
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4213-4222 (2021)
The emergence of immunotherapy revolutionized the treatment of non-small-cell-lung cancer (NSCLC), with multiple landmark clinical trials establishing the efficacy of these agents. However, many patients who receive immunotherapy in clinical practice
Externí odkaz:
https://doaj.org/article/ef1a3db40d2d4a92a300be45448be0e8
Publikováno v:
Breast, Vol 54, Iss , Pp 171-178 (2020)
Introduction: The results of clinical trials in metastatic breast cancer (MBC) are generalized to real-world patients. This study determines the proportion of real-world patients who would be eligible for clinical trials and compares outcomes in elig
Externí odkaz:
https://doaj.org/article/b37634b95dcd4e8ca7a31bc8194940a7